ACA
Overvalued by 33.4% based on the discounted cash flow analysis.
Market cap | $4.85 Billion |
---|---|
Enterprise Value | $6.46 Billion |
Dividend Yield | $0.20 (0.20%) |
Earnings per Share | $1.92 |
Beta | 1.01 |
Outstanding Shares | 48,900,000 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 52.48 |
---|---|
PEG | 169.72 |
Price to Sales | 1.82 |
Price to Book Ratio | 1.97 |
Enterprise Value to Revenue | 2.41 |
Enterprise Value to EBIT | 34.42 |
Enterprise Value to Net Income | 70 |
Total Debt to Enterprise | 0.28 |
Debt to Equity | 0.73 |
No data
No data